• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of cmrPermissionsJournals.ASM.orgJournalCMR ArticleJournal InfoAuthorsReviewers
Clin Microbiol Rev. Oct 1994; 7(4): 479–504.
PMCID: PMC358338

Taxonomy, biology, and clinical aspects of Fusarium species.

Abstract

There are several taxonomic systems available for identifying Fusarium species. The philosophy used in each taxonomic system is discussed as well as problems encountered in working with Fusarium species in culture. Fusarium species are toxigenic, and the mycotoxins produced by these organisms are often associated with animal and human diseases. The implications for the association of the carcinogens, fumonisins, produced by Fusarium moniliforme and other Fusarium species with human diseases are discussed. Foreign-body-associated fusarial infection such as keratitis in contact lens wearers, onychomycosis, skin infections, and disseminated multiorgan infections are discussed. Disseminated fusarial hyalohyphomycosis has emerged as a significant, usually fatal infection in the immunocompromised host. Successful outcome is determined by the degree of immunosuppression, the extent of the infection, and the presence of a removable focus such as an indwelling central venous catheter. These infections may be clinically suspected on the basis of a constellation of clinical and laboratory findings, which should lead to prompt therapy, probably with one of the newer antifungal agents. Perhaps the use of such agents or the use of colony-stimulating factors may improve the outcome of this devastating infection. However, until new approaches for treatment develop, effective preventive measures are urgently needed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (7.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abramowsky CR, Quinn D, Bradford WD, Conant NF. Systemic infection by fusarium in a burned child. The emergence of a saprophytic strain. J Pediatr. 1974 Apr;84(4):561–564. [PubMed]
  • Adetosoye AI, Adene DF. The response of chickens to experimental infection with Fusarium spp. Bull Anim Health Prod Afr. 1978 Jun;26(2):198–120. [PubMed]
  • Alvarez-Franco M, Reyes-Mugica M, Paller AS. Cutaneous Fusarium infection in an adolescent with acute leukemia. Pediatr Dermatol. 1992 Mar;9(1):62–65. [PubMed]
  • Anaissie EJ, Hachem R, Legrand C, Legenne P, Nelson P, Bodey GP. Lack of activity of amphotericin B in systemic murine fusarial infection. J Infect Dis. 1992 Jun;165(6):1155–1157. [PubMed]
  • Anaissie E, Kantarjian H, Jones P, Barlogie B, Luna M, Lopez-Berestein G, Bodey GP. Fusarium. A newly recognized fungal pathogen in immunosuppressed patients. Cancer. 1986 Jun 1;57(11):2141–2145. [PubMed]
  • Anaissie E, Nelson P, Beremand M, Kontoyiannis D, Rinaldi M. Fusarium-caused hyalohyphomycosis: an overview. Curr Top Med Mycol. 1992;4:231–249. [PubMed]
  • Anaissie EJ, Kontoyiannis DP, Vartivarian S, Kantarjian HM, O'Brien S, Giralt SA, Andersson BS, Karl C, Champlin RE, Bodey GP. Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304. Clin Infect Dis. 1993 Dec;17(6):1022–1031. [PubMed]
  • Ando N, Takatori K. Fungal flora of the conjunctival sac. Am J Ophthalmol. 1982 Jul;94(1):67–74. [PubMed]
  • Attapattu MC, Anandakrishnan C. Extensive subcutaneous hyphomycosis caused by Fusarium oxysporum. J Med Vet Mycol. 1986 Apr;24(2):105–111. [PubMed]
  • Barrios NJ, Kirkpatrick DV, Murciano A, Stine K, Van Dyke RB, Humbert JR. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am J Pediatr Hematol Oncol. 1990 Fall;12(3):319–324. [PubMed]
  • Baudraz-Rosselet F, Monod M, Borradori L, Ginalsky JM, Vion B, Boccard C, Frenk E. Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. Dermatology. 1992;184(4):303–305. [PubMed]
  • Becker WK, Cioffi WG, Jr, McManus AT, Kim SH, McManus WF, Mason AD, Pruitt BA., Jr Fungal burn wound infection. A 10-year experience. Arch Surg. 1991 Jan;126(1):44–48. [PubMed]
  • Benjamin RP, Callaway L, Conant NF. Facial granuloma associated with fusarium infection. Arch Dermatol. 1970 May;101(5):598–600. [PubMed]
  • Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet. 1989 Jan 7;1(8628):35–37. [PubMed]
  • Bhavanishankar TN, Ramesh HP, Shantha T. Dermal toxicity of Fusarium toxins in combinations. Arch Toxicol. 1988 Jan;61(3):241–244. [PubMed]
  • Bjeldanes LF, Thomson SV. Mutagenic activity of Fusarium moniliforme isolates in the Salmonella typhimurium assay. Appl Environ Microbiol. 1979 Jun;37(6):1118–1121. [PMC free article] [PubMed]
  • Blazar BR, Hurd DD, Snover DC, Alexander JW, McGlave PB. Invasive Fusarium infections in bone marrow transplant recipients. Am J Med. 1984 Oct;77(4):645–651. [PubMed]
  • Bourguignon RL, Walsh AF, Flynn JC, Baro C, Spinos E. Fusarium species osteomyelitis. Case report. J Bone Joint Surg Am. 1976 Jul;58(5):722–723. [PubMed]
  • BURDA CD, FISHER E., Jr The use of cortisone in establishing experimental fungal keratitis in rats: a preliminary report. Am J Ophthalmol. 1959 Sep;48(3):330–335. [PubMed]
  • Caplin I, Unger DL. Molds on the Southern California deserts. Ann Allergy. 1983 Apr;50(4):260–263. [PubMed]
  • Charles AM, Callender M, Grosvenor T. Efficacy of chemical asepticizing system for soft contact lenses. Am J Optom Arch Am Acad Optom. 1973 Oct;50(10):777–781. [PubMed]
  • Chiaradia V, Schinella D, Pascoli L, Tesio F, Santini GF. Fusarium peritonitis in peritoneal dialysis: report of two cases. Microbiologica. 1990 Jan;13(1):77–78. [PubMed]
  • Cho CT, Vats TS, Lowman JT, Brandsberg JW, Tosh FE. Fusarium solani infection during treatment for acute leukemia. J Pediatr. 1973 Dec;83(6):1028–1031. [PubMed]
  • Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science. 1987 Jun 5;236(4806):1229–1237. [PubMed]
  • Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. Fungal flora of the normal human small and large intestine. N Engl J Med. 1969 Mar 20;280(12):638–641. [PubMed]
  • Cole RJ, Kirksey JW, Cutler HG, Doupnik BL, Peckham JC. Toxin from Fusarium moniliforme: Effects on Plants and Animals. Science. 1973 Mar 30;179(4080):1324–1326. [PubMed]
  • Collins MS, Rinaldi MG. Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia. 1977 Jul;15(2):151–160. [PubMed]
  • Doerr JA, Huff WE, Tung HT, Wyatt RD, Hamilton PB. A survey of T-2 toxin, ochratoxin, and aflatoxin for their effects on the coagulation of blood in young broiler chickens. Poult Sci. 1974 Sep;53(5):1728–1734. [PubMed]
  • Donzis PB, Mondino BJ, Weissman BA, Bruckner DA. Microbial contamination of contact lens care systems. Am J Ophthalmol. 1987 Oct 15;104(4):325–333. [PubMed]
  • Durán JA, Malvar A, Pereiro M, Pereiro M. Fusarium moniliforme keratitis. Acta Ophthalmol (Copenh) 1989 Dec;67(6):710–713. [PubMed]
  • el-Ani AS. Disseminated infection caused by Fusarium solani in a patient with aplastic anemia. N Y State J Med. 1990 Dec;90(12):609–610. [PubMed]
  • English MP. Invasion of the skin by filamentous non-dermatophyte fungi. Br J Dermatol. 1968 May;80(5):282–286. [PubMed]
  • English MP, Smith RJ, Harman RR. The fungal flora of ulcerated legs. Br J Dermatol. 1971 Jun;84(6):567–581. [PubMed]
  • Fitzsimons R, Peters AL. Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. Am J Ophthalmol. 1986 May 15;101(5):605–608. [PubMed]
  • Forsell JH, Witt MF, Tai JH, Jensen R, Pestka JJ. Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone. Food Chem Toxicol. 1986 Mar;24(3):213–219. [PubMed]
  • Forster RK, Rebell G. Animal model of Fusarium solani keratitis. Am J Ophthalmol. 1975 Mar;79(3):510–515. [PubMed]
  • Friend SC, Babiuk LA, Schiefer HB. The effects of dietary T-2 toxin on the immunological function and herpes simplex reactivation in Swiss mice. Toxicol Appl Pharmacol. 1983 Jun 30;69(2):234–244. [PubMed]
  • Fromentin H, Salazar-Mejicanos S, Mariat F. Experimental cryptococcosis in mice treated with diacetoxyscirpenol, a mycotoxin of fusarium. Sabouraudia. 1981 Dec;19(4):311–313. [PubMed]
  • Gamis AS, Gudnason T, Giebink GS, Ramsay NK. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis. 1991 Nov-Dec;13(6):1077–1088. [PubMed]
  • Gelderblom WC, Kriek NP, Marasas WF, Thiel PG. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis. 1991 Jul;12(7):1247–1251. [PubMed]
  • Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. Fumonisins--novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol. 1988 Jul;54(7):1806–1811. [PMC free article] [PubMed]
  • Gelderblom WC, Thiel PG, Jaskiewicz K, Marasas WF. Investigations on the carcinogenicity of fusarin C--a mutagenic metabolite of Fusarium moniliforme. Carcinogenesis. 1986 Nov;7(11):1899–1901. [PubMed]
  • Gelderblom WC, Thiel PG, van der Merwe KJ, Marasas WF, Spies HS. A mutagen produced by Fusarium moniliforme. Toxicon. 1983;21(4):467–473. [PubMed]
  • Gerberick GF, Sorenson WG. Toxicity of T-2 toxin, a Fusarium mycotoxin, to alveolar macrophages in vitro. Environ Res. 1983 Dec;32(2):269–285. [PubMed]
  • Girmenia C, Arcese W, Micozzi A, Martino P, Bianco P, Morace G. Onychomycosis as a possible origin of disseminated Fusarium solani infection in a patient with severe aplastic anemia. Clin Infect Dis. 1992 May;14(5):1167–1167. [PubMed]
  • Gradon JD, Lerman A, Lutwick LI. Septic arthritis due to Fusarium moniliforme. Rev Infect Dis. 1990 Jul-Aug;12(4):716–717. [PubMed]
  • Harrison LR, Colvin BM, Greene JT, Newman LE, Cole JR., Jr Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest. 1990 Jul;2(3):217–221. [PubMed]
  • Haschek WM, Motelin G, Ness DK, Harlin KS, Hall WF, Vesonder RF, Peterson RE, Beasley VR. Characterization of fumonisin toxicity in orally and intravenously dosed swine. Mycopathologia. 1992 Feb;117(1-2):83–96. [PubMed]
  • Hatherill JR, Till GO, Bruner LH, Ward PA. Thermal injury, intravascular hemolysis, and toxic oxygen products. J Clin Invest. 1986 Sep;78(3):629–636. [PMC free article] [PubMed]
  • Hay RJ, Mackenzie DW. Mycetoma (madura foot) in the United Kingdom--a survey of forty-four cases. Clin Exp Dermatol. 1983 Sep;8(5):553–562. [PubMed]
  • Helm TN, Longworth DL, Hall GS, Bolwell BJ, Fernandez B, Tomecki KJ. Case report and review of resolved fusariosis. J Am Acad Dermatol. 1990 Aug;23(2 Pt 2):393–398. [PubMed]
  • Hemo I, Pe'er J, Polacheck I. Fusarium oxysporum keratitis. Ophthalmologica. 1989;198(1):3–7. [PubMed]
  • Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani. J Rheumatol. 1983 Feb;10(1):151–153. [PubMed]
  • Joffe AZ. Environmental conditions conducive to Fusarium toxin formation causing serious outbreaks in animals and man. Vet Res Commun. 1983 Dec;7(1-4):187–193. [PubMed]
  • Joffe AZ. A modern system of Fusarium taxonomy. Mycopathol Mycol Appl. 1974 Aug 30;53(1):201–228. [PubMed]
  • Jones BR, Jones DB, Lim AS, Bron AJ, Morgan G, Clayton YM. Corneal and intra-ocular infection due to Fusarium solani. Trans Ophthalmol Soc U K. 1970;89:757–779. [PubMed]
  • Jones DB. Pathogenesis of bacterial and fungal keratitis. Trans Ophthalmol Soc U K. 1978 Sep;98(3):367–371. [PubMed]
  • Jones DB, Forster FK, Rebell G. Fusarium solani keratitis treated with natamycin (pimaricin): eighteen consecutive cases. Arch Ophthalmol. 1972 Aug;88(2):147–154. [PubMed]
  • Jones DB, Sexton R, Rebell G. Mycotic keratitis in South Florida: a review of thirty-nine cases. Trans Ophthalmol Soc U K. 1970;89:781–797. [PubMed]
  • Kellerman TS, Marasas WF, Thiel PG, Gelderblom WC, Cawood M, Coetzer JA. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J Vet Res. 1990 Dec;57(4):269–275. [PubMed]
  • Kerr CM, Perfect JR, Craven PC, Jorgensen JH, Drutz DJ, Shelburne JD, Gallis HA, Gutman RA. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med. 1983 Sep;99(3):334–336. [PubMed]
  • Khairallah SH, Byrne KA, Tabbara KF. Fungal keratitis in Saudi Arabia. Doc Ophthalmol. 1992;79(3):269–276. [PubMed]
  • Kiehn TE, Nelson PE, Bernard EM, Edwards FF, Koziner B, Armstrong D. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J Clin Microbiol. 1985 Apr;21(4):501–504. [PMC free article] [PubMed]
  • Kiryu H, Yoshida S, Suenaga Y, Asahi M. Invasion and survival of Fusarium solani in the dexamethasone-treated cornea of rabbits. J Med Vet Mycol. 1991;29(6):395–406. [PubMed]
  • Kombila M, Gomez de Diaz M, de Bièvre C, Crepet G, Debrie JC, Belembaogo E, Richard-Lenoble D. Les otites mycosiques à Libreville. Etude de 83 cas. Bull Soc Pathol Exot Filiales. 1989;82(2):201–207. [PubMed]
  • Kriek NP, Marasas WF, Thiel PG. Hepato- and cardiotoxicity of Fusarium verticillioides (F. moniliforme) isolates from Southern African maize. Food Cosmet Toxicol. 1981 Aug;19(4):447–456. [PubMed]
  • Kriek NP, Kellerman TS, Marasas WF. A comparative study of the toxicity of Fusarium verticillioides (= F. moniliforme) to horses, primates, pigs, sheep and rats. Onderstepoort J Vet Res. 1981 Jun;48(2):129–131. [PubMed]
  • Landau M, Srebrnik A, Wolf R, Bashi E, Brenner S. Systemic ketoconazole treatment for Fusarium leg ulcers. Int J Dermatol. 1992 Jul;31(7):511–512. [PubMed]
  • Legrand C, Anaissie E, Hashem R, Nelson P, Bodey GP, Ro J. Experimental fusarial hyalohyphomycosis in a murine model. J Infect Dis. 1991 Nov;164(5):944–948. [PubMed]
  • Lieberman TW, Ferry AP, Bottone EJ. Fusarium solani endophthalmitis without primary corneal involvement. Am J Ophthalmol. 1979 Oct;88(4):764–767. [PubMed]
  • Madhavan M, Ratnakar C, Veliath AJ, Kanungo R, Smile SR, Bhat S. Primary disseminated fusarial infection. Postgrad Med J. 1992 Feb;68(796):143–144. [PMC free article] [PubMed]
  • Marasas WF, Kellerman TS, Gelderblom WC, Coetzer JA, Thiel PG, van der Lugt JJ. Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res. 1988 Dec;55(4):197–203. [PubMed]
  • Marasas WF, Kriek NP, Fincham JE, van Rensburg SJ. Primary liver cancer and oesophageal basal cell hyperplasia in rats caused by Fusarium moniliforme. Int J Cancer. 1984 Sep 15;34(3):383–387. [PubMed]
  • Marasas WF, van Rensburg SJ, Mirocha CJ. Incidence of Fusarium species and the mycotoxins, deoxynivalenol and zearalenone, in corn produced in esophageal cancer areas in Transkei. J Agric Food Chem. 1979 Sep-Oct;27(5):1108–1112. [PubMed]
  • Matsuda T, Matsumoto T. Disseminated hyalohyphomycosis in a leukemic patient. Arch Dermatol. 1986 Oct;122(10):1171–1175. [PubMed]
  • Merz WG, Karp JE, Hoagland M, Jett-Goheen M, Junkins JM, Hood AF. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis. 1988 Nov;158(5):1046–1055. [PubMed]
  • Miño de Kaspar H, Zoulek G, Paredes ME, Alborno R, Medina D, Centurion de Morinigo M, Ortiz de Fresco M, Aguero F. Mycotic keratitis in Paraguay. Mycoses. 1991 May-Jun;34(5-6):251–254. [PubMed]
  • Minor RL, Jr, Pfaller MA, Gingrich RD, Burns LJ. Disseminated Fusarium infections in patients following bone marrow transplantation. Bone Marrow Transplant. 1989 Nov;4(6):653–658. [PubMed]
  • Morel-Chany E, Burtin P, Trincal G, Frayssinet C. Cytostatic effects of T2 toxin on cultured human neoplastic cells of intestinal origin. Bull Cancer. 1980;67(2):149–154. [PubMed]
  • Mowbray DN, Paller AS, Nelson PE, Kaplan RL. Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol. 1988 Dec;27(10):698–701. [PubMed]
  • Mutton KJ, Lucas TJ, Harkness JL. Disseminated fusarium infection. Med J Aust. 1980 Nov 29;2(11):624–625. [PubMed]
  • Nadler JP. Disseminated fusarial infection. Rev Infect Dis. 1990 Jan-Feb;12(1):162–162. [PubMed]
  • Nati R, Dreyfus F, Lanore JJ, Brunet F, Robin P, Bordier C, Dupouy-Camet J. Localisations cutanées d'une septicémie à Fusarium oxysporum survenant chez un patient en aplasie médullaire. Ann Dermatol Venereol. 1988;115(3):337–338. [PubMed]
  • Nelson PE. Taxonomy and biology of Fusarium moniliforme. Mycopathologia. 1992 Feb;117(1-2):29–36. [PubMed]
  • Nelson PE, Plattner RD, Shackelford DD, Desjardins AE. Production of fumonisins by Fusarium moniliforme strains from various substrates and geographic areas. Appl Environ Microbiol. 1991 Aug;57(8):2410–2412. [PMC free article] [PubMed]
  • Nelson PE, Plattner RD, Shackelford DD, Desjardins AE. Fumonisin B1 production by Fusarium species other than F. moniliforme in section Liseola and by some related species. Appl Environ Microbiol. 1992 Mar;58(3):984–989. [PMC free article] [PubMed]
  • Norred WP, Wang E, Yoo H, Riley RT, Merrill AH., Jr In vitro toxicology of fumonisins and the mechanistic implications. Mycopathologia. 1992 Feb;117(1-2):73–78. [PubMed]
  • Notermans S, Dufrenne J, Wijnands LM, Engel HW. Human serum antibodies to extracellular polysaccharides (EPS) of moulds. J Med Vet Mycol. 1988 Feb;26(1):41–48. [PubMed]
  • Nuovo MA, Simmonds JE, Chacho MS, McKitrick JC. Fusarium solani osteomyelitis with probable nosocomial spread. Am J Clin Pathol. 1988 Dec;90(6):738–741. [PubMed]
  • O'Day DM, Akrabawi PL, Richmond LD, Jones BR, Clayton Y. An animal model of Fusarium solani endophthalmitis. Br J Ophthalmol. 1979 Apr;63(4):277–280. [PMC free article] [PubMed]
  • O'Day DM, Head WS, Robinson RD, Clanton JA. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res. 1986 Nov;5(11):877–882. [PubMed]
  • Okuda C, Ito M, Sato Y, Oka K, Hotchi M. Disseminated cutaneous Fusarium infection with vascular invasion in a leukemic patient. J Med Vet Mycol. 1987 Jun;25(3):177–186. [PubMed]
  • Page JC, Friedlander G, Dockery GL. Postoperative fusarium osteomyelitis. J Foot Surg. 1982 Fall;21(3):174–176. [PubMed]
  • Patoux-Pibouin M, Couatarmanach A, Le Gall F, Bergeron C, De Bièvre C, Guiguen C, Chevrant-Breton J. Fusariose à Fusarium solani chez un adolescent leucémique. Ann Dermatol Venereol. 1992;119(5):377–380. [PubMed]
  • Patterson JW, Brown PC, Broecker AH. Infection-induced panniculitis. J Cutan Pathol. 1989 Aug;16(4):183–193. [PubMed]
  • Pérez-Comas A, Saénz de Rodríguez CA, Sánchez Lugo F. Anomalías de desarrollo sexual en Puerto Rico: estado de situación. Bol Asoc Med P R. 1991 Jul;83(7):306–309. [PubMed]
  • Pestka JJ, Tai JH, Witt MF, Dixon DE, Forsell JH. Suppression of immune response in the B6C3F1 mouse after dietary exposure to the Fusarium mycotoxins deoxynivalenol (vomitoxin) and zearalenone. Food Chem Toxicol. 1987 Apr;25(4):297–304. [PubMed]
  • Pflugfelder SC, Flynn HW, Jr, Zwickey TA, Forster RK, Tsiligianni A, Culbertson WW, Mandelbaum S. Exogenous fungal endophthalmitis. Ophthalmology. 1988 Jan;95(1):19–30. [PubMed]
  • Pitts RE, Krachmer JH. Evaluation of soft contact lens disinfection in the home environment. Arch Ophthalmol. 1979 Mar;97(3):470–472. [PubMed]
  • Bacon SP. Effect of masker level on overshoot. J Acoust Soc Am. 1990 Aug;88(2):698–702. [PubMed]
  • Plattner RD, Shackelford DD. Biosynthesis of labeled fumonisins in liquid cultures of Fusarium moniliforme. Mycopathologia. 1992 Feb;117(1-2):17–22. [PubMed]
  • Qureshi MA, Hagler WM., Jr Effect of fumonisin-B1 exposure on chicken macrophage functions in vitro. Poult Sci. 1992 Jan;71(1):104–112. [PubMed]
  • Raicu MD. Infecţie diseminată cu Fusarium sp. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1983 Jan-Mar;28(1):69–74. [PubMed]
  • Rajasekaran J, Thomas PA, Kalavathy CM, Joseph PC, Abraham DJ. Itraconazole therapy for fungal keratitis. Indian J Ophthalmol. 1987;35(5-6):157–160. [PubMed]
  • Reuben A, Anaissie E, Nelson PE, Hashem R, Legrand C, Ho DH, Bodey GP. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrob Agents Chemother. 1989 Sep;33(9):1647–1649. [PMC free article] [PubMed]
  • Richardson SE, Bannatyne RM, Summerbell RC, Milliken J, Gold R, Weitzman SS. Disseminated fusarial infection in the immunocompromised host. Rev Infect Dis. 1988 Nov-Dec;10(6):1171–1181. [PubMed]
  • Rippon JW, Larson RA, Rosenthal DM, Clayman J. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature. Mycopathologia. 1988 Feb;101(2):105–111. [PubMed]
  • Robertson MJ, Socinski MA, Soiffer RJ, Finberg RW, Wilson C, Anderson KC, Bosserman L, Sang DN, Salkin IF, Ritz J. Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant. 1991 Aug;8(2):143–145. [PubMed]
  • Rokicka-Milewska R, Derulska D, Lipnicki D, Skrobowska-Woźniak A, Moszczeńska A. The use of 2.5% natamycin, as orally administered drops, in the treatment of fungal infections of the oral cavity in children with chronic blood diseases. J Int Med Res. 1989 Jan-Feb;17(1):82–86. [PubMed]
  • Rosenstein Y, Kretschmer RR, Lafarge-Frayssinet C. Effect of Fusarium toxins, T2-toxin and diacetoxyscirpenol on murine T-independent immune responses. Immunology. 1981 Nov;44(3):555–560. [PMC free article] [PubMed]
  • Rosenstein Y, Lafarge-Frayssinet C, Lespinats G, Loisillier F, Lafont P, Frayssinet C. Immunosuppressive activity of Fusarium toxins. Effects on antibody synthesis and skin grafts of crude extracts, T2-toxin and diacetoxyscirpenol. Immunology. 1979 Jan;36(1):111–117. [PMC free article] [PubMed]
  • Ross PF, Nelson PE, Richard JL, Osweiler GD, Rice LG, Plattner RD, Wilson TM. Production of fumonisins by Fusarium moniliforme and Fusarium proliferatum isolates associated with equine leukoencephalomalacia and a pulmonary edema syndrome in swine. Appl Environ Microbiol. 1990 Oct;56(10):3225–3226. [PMC free article] [PubMed]
  • Rotowa NA, Shadomy HJ, Shadomy S. In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens. Mycoses. 1990 Apr;33(4):203–211. [PubMed]
  • Ruben M. Preliminary observations of soft 9(hydrophilic) contact lenses. Proc R Soc Med. 1966 Jun;59(6):531–532. [PMC free article] [PubMed]
  • Rush-Munro FM, Black H, Dingley JM. Onychomycosis caused by fusarium oxysporum. Australas J Dermatol. 1971 Apr;12(1):18–29. [PubMed]
  • Rütten A, Hantschke D, Goos M. Kutane Manifestation einer Pilzsepsis. Hautarzt. 1990 Jul;41(7):392–393. [PubMed]
  • Salazar S, Fromentin H, Mariat F. Action du diacetoxyscirpénol sur la candidose expérimentale de la Souris. C R Seances Acad Sci D. 1980 Mar 31;290(13):877–878. [PubMed]
  • Schneller FR, Gulati SC, Cunningham IB, O'Reilly RJ, Schmitt HJ, Clarkson BD. Fusarium infections in patients with hematologic malignancies. Leuk Res. 1990;14(11-12):961–966. [PubMed]
  • Sharman M, Gilbert J, Chelkowski J. A survey of the occurrence of the mycotoxin moniliformin in cereal samples from sources worldwide. Food Addit Contam. 1991 Jul-Aug;8(4):459–466. [PubMed]
  • Simmons RB, Buffington JR, Ward M, Wilson LA, Ahearn DG. Morphology and ultrastructure of fungi in extended-wear soft contact lenses. J Clin Microbiol. 1986 Jul;24(1):21–25. [PMC free article] [PubMed]
  • SNYDER WC, HANSEN HN. Variation and speciation in the genus Fusarium. Ann N Y Acad Sci. 1954 Oct 29;60(1):16–23. [PubMed]
  • Springer JP, Clardy J, Cole RJ, Kirksey JW, Hill RK, Carlson MR, Isidor JL. Structure and synthesis of moniliformin, a novel cyclobutane microbial toxin. J Am Chem Soc. 1974 Apr 3;96(7):2267–2268. [PubMed]
  • Steinberg GK, Britt RH, Enzmann DR, Finlay JL, Arvin AM. Fusarium brain abscess. Case report. J Neurosurg. 1983 Apr;58(4):598–601. [PubMed]
  • Strelow SA, Kent HD, Eagle RC, Jr, Cohen EJ. A case of contact lens related Fusarium solani keratitis. CLAO J. 1992 Apr;18(2):125–127. [PubMed]
  • Sturm AW, Grave W, Kwee WS. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet. 1989 Apr 29;1(8644):968–968. [PubMed]
  • Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia. 1989 Apr;106(1):13–22. [PubMed]
  • Sundaram BM, Badrinath S, Subramanian S. Studies on mycotic keratitis. Mycoses. 1989 Nov;32(11):568–572. [PubMed]
  • Thiel PG, Marasas WF, Sydenham EW, Shephard GS, Gelderblom WC, Nieuwenhuis JJ. Survey of fumonisin production by Fusarium species. Appl Environ Microbiol. 1991 Apr;57(4):1089–1093. [PMC free article] [PubMed]
  • Torres MA, Mohamed J, Cavazos-Adame H, Martinez LA. Topical ketoconazole for fungal keratitis. Am J Ophthalmol. 1985 Aug 15;100(2):293–298. [PubMed]
  • Uchiyama N, Shindo Y, Mikoshiba H, Saito H. Cutaneous infection caused by Fusarium solani and Fusarium oxysporum. J Dermatol. 1987 Oct;14(5):471–475. [PubMed]
  • Vajpayee RB, Gupta SK, Bareja U, Kishore K. Ocular atopy and mycotic keratitis. Ann Ophthalmol. 1990 Oct;22(10):369–372. [PubMed]
  • Valenstein P, Schell WA. Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomycosis. Arch Pathol Lab Med. 1986 Aug;110(8):751–754. [PubMed]
  • Veglia KS, Marks VJ. Fusarium as a pathogen. A case report of Fusarium sepsis and review of the literature. J Am Acad Dermatol. 1987 Jan;16(1 Pt 2):260–263. [PubMed]
  • Vélez H, Díaz F. Onychomycosis due to saprophytic fungi. Report of 25 cases. Mycopathologia. 1985 Aug;91(2):87–92. [PubMed]
  • Venditti M, Micozzi A, Gentile G, Polonelli L, Morace G, Bianco P, Avvisati G, Papa G, Martino P. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis. 1988 May-Jun;10(3):653–660. [PubMed]
  • Venugopal PL, Venugopal TL, Gomathi A, Ramakrishna ES, Ilavarasi S. Mycotic keratitis in Madras. Indian J Pathol Microbiol. 1989 Jul;32(3):190–197. [PubMed]
  • Vidal D, Mavet S. In vitro and in vivo toxicity of T-2 toxin, a Fusarium mycotoxin, to mouse peritoneal macrophages. Infect Immun. 1989 Jul;57(7):2260–2264. [PMC free article] [PubMed]
  • Viscoli C, Castagnola E, Moroni C, Garaventa A, Manno G, Savioli C. Infection with Fusarium species in two children with neuroblastoma. Eur J Clin Microbiol Infect Dis. 1990 Oct;9(10):773–776. [PubMed]
  • Visconti A, Minervini F, Lucivero G, Gambatesa V. Cytotoxic and immunotoxic effects of Fusarium mycotoxins using a rapid colorimetric bioassay. Mycopathologia. 1991 Mar;113(3):181–186. [PubMed]
  • Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol. 1981 Mar;75(3):304–311. [PubMed]
  • Wilhelmus KR, Robinson NM, Font RA, Hamill MB, Jones DB. Fungal keratitis in contact lens wearers. Am J Ophthalmol. 1988 Dec 15;106(6):708–714. [PubMed]
  • Williams G, Billson F, Husain R, Howlader SA, Islam N, McClellan K. Microbiological diagnosis of suppurative keratitis in Bangladesh. Br J Ophthalmol. 1987 Apr;71(4):315–321. [PMC free article] [PubMed]
  • Wilson LA, Ahearn DG, Jones DB, Sexton RR. Fungi from the normal outer eye. Am J Ophthalmol. 1969 Jan;67(1):52–56. [PubMed]
  • Wilson TM, Nelson PE, Knepp CR. Hepatic neoplastic nodules, adenofibrosis, and cholangiocarcinomas in male Fisher 344 rats fed corn naturally contaminated with Fusarium moniliforme. Carcinogenesis. 1985 Aug;6(8):1155–1160. [PubMed]
  • Wilson TM, Ross PF, Owens DL, Rice LG, Green SA, Jenkins SJ, Nelson HA. Experimental reproduction of ELEM. A study to determine the minimum toxic dose in ponies. Mycopathologia. 1992 Feb;117(1-2):115–120. [PubMed]
  • Yamaguchi T, Hubbard A, Fukushima A, Kimura T, Kaufman HE. Fungus growth on soft contact lenses with different water contents. CLAO J. 1984 Apr-Jun;10(2):166–171. [PubMed]
  • Yang CS. Research on esophageal cancer in China: a review. Cancer Res. 1980 Aug;40(8 Pt 1):2633–2644. [PubMed]
  • Yarom R, More R, Eldor A, Yagen B. The effect of T-2 toxin on human platelets. Toxicol Appl Pharmacol. 1984 Apr;73(2):210–217. [PubMed]
  • Yarom R, More R, Sherman Y, Yagen B. T-2 toxin-induced pathology in the hearts of rats. Br J Exp Pathol. 1983 Oct;64(5):570–577. [PMC free article] [PubMed]
  • Yarom R, Sherman Y, More R, Ginsburg I, Borinski R, Yagen B. T-2 toxin effect on bacterial infection and leukocyte functions. Toxicol Appl Pharmacol. 1984 Aug;75(1):60–68. [PubMed]
  • Yoo HS, Norred WP, Wang E, Merrill AH, Jr, Riley RT. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl Pharmacol. 1992 May;114(1):9–15. [PubMed]
  • Young CN, Meyers AM. Opportunistic fungal infection by Fusarium oxysporum in a renal transplant patient. Sabouraudia. 1979 Sep;17(3):219–223. [PubMed]
  • Young JB, Ahmed-Jushuf IH, Brownjohn AM, Parsons FM, Foulkes SJ, Evans EG. Opportunistic peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol. 1984 Nov;22(5):268–269. [PubMed]
  • Young NA, Kwon-Chung KJ, Kubota TT, Jennings AE, Fisher RI. Disseminated infection by Fusarium moniliforme during treatment for malignant lymphoma. J Clin Microbiol. 1978 Jun;7(6):589–594. [PMC free article] [PubMed]
  • Zach TL, Penn RG, Gnarra DJ, Bever JL. Fusarium moniliforme pneumonia. Nebr Med J. 1987 Jan;72(1):6–9. [PubMed]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...